0001209191-20-032947.txt : 20200529
0001209191-20-032947.hdr.sgml : 20200529
20200529163214
ACCESSION NUMBER: 0001209191-20-032947
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200528
FILED AS OF DATE: 20200529
DATE AS OF CHANGE: 20200529
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Collard Craig A
CENTRAL INDEX KEY: 0001363558
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37490
FILM NUMBER: 20928460
BUSINESS ADDRESS:
BUSINESS PHONE: 919-678-6611
MAIL ADDRESS:
STREET 1: C/O CORNERSTONE THERAPEUTICS INC.
STREET 2: 1255 CRESCENT GREEN DRIVE, SUITE 250
CITY: CARY
STATE: NC
ZIP: 27518
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Sierra Oncology, Inc.
CENTRAL INDEX KEY: 0001290149
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2150 ? 885 WEST GEORGIA STREET
CITY: VANCOUVER
STATE: A1
ZIP: V6C 3E8
BUSINESS PHONE: 604-558-6536
MAIL ADDRESS:
STREET 1: 2150 ? 885 WEST GEORGIA STREET
CITY: VANCOUVER
STATE: A1
ZIP: V6C 3E8
FORMER COMPANY:
FORMER CONFORMED NAME: ProNAi Therapeutics Inc
DATE OF NAME CHANGE: 20040513
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2020-05-28
0
0001290149
Sierra Oncology, Inc.
SRRA
0001363558
Collard Craig A
C/O SIERRA ONCOLOGY, INC.
2150 885 WEST GEORGIA ST.
VANCOUVER
A1
V6C 3E8
BRITISH COLUMBIA, CANADA
1
0
0
0
Stock Option (right to buy)
13.88
2020-05-28
4
A
0
10000
0.00
A
2030-05-28
Common Stock
10000
10000
D
The option vests as to 1/12 of the total shares monthly, beginning on June 28, 2020, with 100% of the total shares vested and exercisable on May 28, 2021, subject to the Reporting Person's provision of service to the issuer on each vesting date.
/s/ Sukhi Jagpal as attorney-in-fact for Craig A. Collard
2020-05-29